3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
17
Fallopian Tube Neoplasms
17
Glioblastoma
7
Colorectal Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Lung Neoplasms
6
Carcinoma, Renal Cell
6
Brenner Tumor
6
Melanoma
5
Uterine Cervical Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Gliosarcoma
4
Breast Neoplasms
4
Brain Neoplasms
4
Triple Negative Breast Neoplasms
3
Recurrent Squamous Cell Lung Carcinoma
3
Oligodendroglioma
3
Neoplasm Metastasis
3
Lymphoma, Large B-Cell, Diffuse
3
Colonic Neoplasms
3
Uveal Melanoma
2
Spinal Cord Neoplasms
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Medulloblastoma
2
Glioma
2
Endometrial Adenocarcinoma
2
Carcinoma
2
Astrocytoma
2
Adenocarcinoma of Lung
2
Interventions
pembrolizumab
4
Cisplatin
4
Gemcitabine
3
Carboplatin
3
Docetaxel
2
Bupropion
2
tocilizumab
1
tislelizumab
1
spartalizumab
1
infigratinib
1
etoposide phosphate
1
cc-486
1
avelumab
1
Zoledronic Acid
1
Vorinostat
1
Varenicline
1
Tobacco Use Cessation Devices
1
Radiotherapy, Intensity-Modulated
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Pilocarpine
1
Oral Hygiene
1
Nivolumab
1
Nicotine Replacement Therapy
1
Nicotine
1
NVP-BKM120
1
Ifosfamide
1
Gene Expression Profiling
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Nasopharyngeal Neoplasms
×
Disulfides
×
Clear all
No trials found.